Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
-2.17%
trims when stocks drop
when a holding falls −10%+
Middle response
-3.22%
baseline attrition
Rally response
-1.82%
trims into rallies
when a holding rises +10%+
Top positions · 16
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| PTGXProtagonist Therapeutics | $258M | 39.6% | +117.9% | 4.8 yr |
| NBTXNanobiotix S.A. | $174M | 26.6% | +762.3% | 2.8 yr |
| MGTXMeiraGTx Holdings plc | $58M | 8.8% | +27.7% | 4.8 yr |
| RAPPRapport Therapeutics, In | $56M | 8.6% | +212.0% | 2.0 yr |
| CVRXCVRx, Inc. | $38M | 5.8% | -22.6% | 4.8 yr |
| CTNMContineum Therapeutics, | $26M | 4.0% | +87.1% | 2.0 yr |
| LEGNLegend Biotech Corporati | $15M | 2.3% | -46.7% | 4.8 yr |
| XNCRXencor, Inc. | $9M | 1.4% | +13.3% | 4.5 yr |
| PRCTPROCEPT BioRobotics Corp | $9M | 1.4% | -57.1% | 4.8 yr |
| FATEFate Therapeutics, Inc. | $4M | 0.6% | +51.9% | 4.8 yr |
| NMRANeumora Therapeutics, In | $4M | 0.6% | +95.0% | 2.8 yr |
| RLYBRallybio Corporation | $1M | 0.2% | — | 0.3 yr |
| VORVor Biopharma Inc. | $1M | 0.1% | +24.3% | 0.8 yr |
| LABStandard BioTools Inc. | $0M | 0.0% | -14.9% | 2.3 yr |
| NNOXNano-X Imaging Ltd. | $0M | 0.0% | -54.6% | 4.5 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology92.7%+14.9pp$605M
Medical - Devices7.3%-13.8pp$48M
Unknown0.0%-1.0pp$0M
Country
US73.3%-19.5pp
FR26.6%+20.7pp
IL0.0%-0.2pp
Unknown0.0%-1.0pp
Top 5: 89.4% · Top 10: 99.0% · Top 25: 100.0%
Top buys this quarter · 1
| RLYB Rallybio Corporationnew | +$1M |
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $652M | 16 | +103.12% | +17.59% | +85.53% | -0.00B |
| 2025-12-31 | $555M | 17 | +52.36% | +17.72% | +34.64% | -0.01B |
| 2025-09-30 | $507M | 21 | +21.52% | +17.52% | +4.00% | -0.02B |
| 2025-06-30 | $334M | 20 | -30.48% | +14.94% | -45.42% | -0.00B |
| 2025-03-31 | $342M | 20 | -35.23% | +8.30% | -43.53% | -0.00B |
| 2024-12-31 | $386M | 20 | -25.81% | +24.89% | -50.70% | +0.00B |
| 2024-09-30 | $427M | 20 | -8.92% | +36.04% | -44.96% | +0.07B |
| 2024-06-30 | $401M | 20 | -14.47% | +24.49% | -38.96% | -3.62B |
| 2024-03-31 | $4.41B | 22 | +7.16% | +29.62% | -22.46% | -0.04B |
| 2023-12-31 | $4.39B | 23 | -2.01% | +26.18% | -28.18% | +4.09B |
| 2023-09-30 | $271M | 24 | -25.90% | +21.57% | -47.47% | +0.00B |
| 2023-06-30 | $322M | 22 | -30.71% | +19.42% | -50.14% | -0.03B |
| 2023-03-31 | $307M | 23 | -66.15% | -7.82% | -58.33% | -0.01B |
| 2022-12-31 | $344M | 22 | -16.78% | +7.56% | -24.34% | +0.06B |
| 2022-09-30 | $340M | 22 | -21.41% | -4.93% | -16.48% | +0.03B |
| 2022-06-30 | $391M | 22 | -44.24% | -16.11% | -28.13% | +0.10B |